Influence of local and systemic CTLA4Ig gene transfer on corneal allograft survival

Journal of Gene Medicine

Volumn 8, Issue 4, 2006, Pages 459-467

  Gong, Nianqiao ^a,b   Pleyer, Uwe ^a   Yang, Jun ^a   Vogt, Katrin ^a   Hill, Marcelo ^c   Anegon, Ignacio ^c   Volk, Hans Dieter ^a   Ritter, Thomas ^a,d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c INSERM   (France)

^d NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Adenovirus; Cornea; CTLA4Ig; Gene therapy; Immunodulation; Transplantation

Indexed keywords

ABATACEPT; ADENOVIRUS VECTOR; BETA GALACTOSIDASE; CYTOKINE; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; OFLOXACIN; VIRUS ANTIBODY;

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; CORNEA TRANSPLANTATION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG POTENTIATION; EX VIVO STUDY; FEMALE; GENE EXPRESSION PROFILING; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOMODULATION; IMMUNOREGULATION; LOW DRUG DOSE; MISMATCH REPAIR; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL TIME; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS IMMUNITY; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; ANTIBODIES; CORNEA; CORNEAL TRANSPLANTATION; FEMALE; GENE THERAPY; GRAFT ENHANCEMENT, IMMUNOLOGIC; GRAFT SURVIVAL; IMMUNOCONJUGATES; INTERLEUKIN-10; RATS; RATS, INBRED LEW; RNA, MESSENGER; TRANSDUCTION, GENETIC;

ADENOVIRIDAE; ANIMALIA; HUMAN ADENOVIRUS TYPE 5;

EID: 33646239375     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.876     Document Type: Article

References (38)

1. Pleyer U, Dannowski H, Volk HD, Ritter T. Corneal allograft rejection: current understanding. I. Immunobiology and basic mechanisms. Ophthalmologica 2001; 215: 254-262.
2. Niederkorn JY. Immunology and immunomodulation of corneal transplantation. Int Rev Immunol 2002; 21: 173-196.
3. George AJ, Larkin DF. Corneal transplantation: the forgotten graft. Am J Transplant 2004; 4: 678-685.
4. The Collaborative Corneal Transplantation Studies Research Group. The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. Arch Ophthalmol 1992; 110: 1392-1403.
5. Williams KA, Muehlberg SM, Lewis RF, et al. The Australian Corneal Graft Registry 1996 report. Adelaide Mercury Press: Adelaide, 1997; 11: 47.
6. Geppert TD, Davis LS, Gur H, Wacholtz MC, Lipsky PE. Accessory cell signals involved in T-cell activation. Immunol Rev 1990; 117: 5-66.
7. Jenkins MK. The role of cell division in the induction of clonal anergy. Immunol Today 1992; 13: 69-73.
8. Rothstein DM, Sayegh MH. T-cell costimulatory pathways in allograft rejection and tolerance. Immunol Rev 2003; 196: 85-108.
9. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996; 14: 233-258.
10. Guillot C, Mathieu P, Coathalem H, et al. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression. J Immunol 2000; 164: 5258-5268.
11. Ardjomand N, McAlister JC, Rogers NJ, Tan PH, George AJ, Larkin DF. Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection. Invest Ophthalmol Vis Sci 2003; 44: 3899-3905.
12. Schaub M, Stadlbauer TH, Chandraker A, Vella JP, Turka. LA, Sayegh MH. Comparative strategies to induce long-term graft acceptance in fully allogeneic renal versus cardiac allograft models byCD28-B7 T cell costimulatory blockade: role of thymus and spleen. J Am Soc Nephrol 1998; 9: 891-898.
13. Comer RM, King WJ, Ardjomand N, Theoharis S, George AJ, Larkin DF. Effect of administration of CTLA4Ig as protein or cDNA on corneal allograft survival. Invest Ophthalmol Vis Sci 2002; 43: 1095-1103.
14. Konig Merediz SA, Zhang EP, Wittig B, Hoffmann F. Ballistic transfer of minimalistic immunologically defined expression constructs for IL4 and CTLA4 into the corneal epithelium in mice after orthotopic corneal allograft transplantation. Graefes Arch Clin Exp Ophthalmol 2000; 238: 701-707.
15. Hoffmann F, Zhang EP, Pohl T, Kunzendorf U, Wachtlin J, Bulfone-Paus S. Inhibition of corneal allograft reaction by CTLA4-Ig. Graefes Arch Clin Exp Ophthalmol 1997; 235: 535-540.
16. Thiel MA, Steiger JU, O'Connell PJ, Lehnert AM, Coster DJ, Williams KA. Local or short-term systemic costimulatory molecule blockade prolongs rat corneal allograft survival. Clin Exp Ophthalmol 2005; 33: 176-180.
17. Verwaerde C, Naud MC, Delanoye A, et al. Ocular transfer of retinal glial cells transduced ex vivo with adenovirus expressing viral IL-10 or CTLA4-Ig inhibits experimental autoimmune uveoretinitis. Gene Ther 2003; 10: 1970-1981.
18. Ding L, Shevach EM. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J Immunol 1992; 148: 3133-3139.
19. Barrat FJ, Cua DJ, Boonstra A, et al. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002; 195: 603-616.
20. Moore KW, Vieira P, Fiorentino DF, Trounstine ML, Khan TA, Mosmann TR. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 1990; 248: 1230-1234.
21. Qin L, Ding Y, Pahud DR, Robson ND, Shaked A, Bromberg JS. Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigen. Hum Gene Ther 1997; 8: 1365-1374.
22. David A, Chetritt J, Guillot C, et al. Interleukin-10 produced by recombinant adenovirus prolongs survival of cardiac allografts in rats. Gene Ther 2000; 7: 505-510.
23. Klebe S, Sykes PJ, Coster DJ, Krishnan R, Williams KA. Prolongation of sheep corneal allograft survival by ex vivo transfer of the gene encoding interleukin-10. Transplantation 2001; 71: 1207-1209.
24. Larkin DF, Oral HB, Ring CJ, Lemoine NR, George AJ. Adenovirus-mediated gene delivery to the corneal endothelium. Transplantation 1996; 61: 363-370.
25. Ritter T, Vogt K, Rieck P, et al. Adenovirus-mediated gene transfer of interleukin-4 to corneal endothelial cells and organ cultured corneas leads to high IL-4 expression. Exp Eye Res 1999; 69:563-568.
26. Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 2001; 7: 33-40.
27. Gojo S, Cooper DK, Iacomini J, LeGuern C. Gene therapy and transplantation. Transplantation 2000; 69: 1995-1999.
28. Guillot C, Le Mauff B, Cuturi MC, Anegon I. Gene therapy in transplantation in the year 2000: moving towards clinical applications? Gene Ther 2000; 7: 14-19.
29. Pleyer U. Immunobiology and Prevention of Allograft Reaction after Experimental Keratoplasty, Aeolus Press: Buren, The Netherlands, 1996; 22-23.
30. Hamrah P, Liu Y, Zhang Q, Dana MR. The corneal stroma is endowed with a significant number of resident dendritic cells. Invest Ophthalmol Vis Sci 2003; 44: 581-589.
31. Kolls J, Peppel K, Silva M, Beutler B. Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc Natl Acad Sci USA 1994; 91: 215-219.
32. Tran HM, Nickerson PW, Restifo AC, et al. Distinct mechanisms for the induction and maintenance of allograft tolerance with CTLA4-Fc treatment. J Immunol 1997; 159: 2232-2239.
33. Wallace PM, Rodgers JN, Leytze GM, Johnson JS, Linsley PS. Induction and reversal of long-lived specific unresponsiveness to a T-dependent antigen following CTLA4Ig treatment. J Immunol 1995; 154: 5885-5895.
34. Judge TA, Tang A, Spain LM, Deans-Gratiot J, Sayegh MH, Turka LA. The in vivo mechanism of action of CTLA4Ig. J Immunol 1996; 156: 2294-2299.
35. King WJ, Comer RM, Hudde T, Larkin DF, George AJ. Cytokine and chemokine expression kinetics after corneal transplantation. Transplantation 2000; 70: 1225-1233.
36. Pleyer U, Bertelmann E, Rieck P, et al. Survival of corneal allografts following adenovirus-mediated gene transfer of interleukin-4. Graefes Arch Clin Exp Ophthalmol 2000; 238: 531-536.
37. Fang B, Eisensmith RC, Wang H, et al. Gene therapy for hemophilia B: host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression. Hum Gene Ther 1995; 6: 1039-1044.
38. Ritter T, Lehmann M, Volk HD. Improvements in gene therapy: averting the immune response to adenoviral vectors. BioDrugs 2002; 16: 3-10.